Keywords: Ad; adamantane; Ad-PEG; Ad-methoxypoly(ethylene glycol); Ad-PMT; Ad-poly(methyl chloride-quaternized 2-(dimethylamino)ethyl methacrylate); Ad-PSA; Ad-poly(styrenesulfonate-co-sodium acrylate); AEMA; 2-aminoethyl methacrylate; AgNPs; silver nanoparticles;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: CALR insertion; CALR deletion; Fluorescent PCR; KDEL motif; MPNs
Double sword role of EZH2 in leukemia
Keywords: EZH1,2; enhancer of Zeste 1 and 2; SUZ12; suppressor of zeste 12 homolog; EED; embryonic ectoderm development; AEBP2; adipocyte enhancer-binding protein 2; RBAP46/48; retinoblastoma binding proteins 46 and 48; PRC; polycomb-repressive complex; PcG; Polyco
JAK2 V617F Mutation Status of 232 Patients Diagnosed With Chronic Myeloproliferative Neoplasms
Keywords: Essential thrombocythemia; JAK2 mutation; MPNs; Polycythemia vera; Primary myelofibrosis
The association of the JAK2 46/1 haplotype with non-splanchnic venous thrombosis
Keywords: JAK2; Janus kinase 2; SVT; splanchnic venous thrombosis; non-SVT; non-splanchnic venous thrombosis; MPNs; myeloproliferative neoplasms; SNP; single nucleotide polymorphism; HWE; Hardy-Weinberg equilibrium; AS-PCR; allele-specific polymerase chain reaction
Critical role of FANCC in JAK2 V617F mutant-induced resistance to DNA cross-linking drugs
Keywords: ATM; ataxia-telangiectasia mutated; Epo; erythropoietin; EpoR; erythropoietin receptor; ET; essential thrombocythemia; FA; Fanconi anemia; JAK2; Janus kinase 2; MPNs; myeloproliferative neoplasms; PMF; primary myelofibrosis; PV; polycythemia vera; RT-PCR;
Fullerene derivative prevents cellular transformation induced by JAK2 V617F mutant through inhibiting c-Jun N-terminal kinase pathway
Keywords: Cdk4; cyclin-dependent kinase 4; DCFH; dichlorodihydrofluorescein; DMSO; dimethyl sulfoxide; Epo; erythropoetin; ERK; extracellular signal-regulated kinase; FBS; fetal bovine serum; i.p.; intraperitoneal; i.v.; intravenous; Jak; Janus kinase; JNK; c-Jun N
Aurora kinase A critically contributes to the resistance to anti-cancer drug cisplatin in JAK2 V617F mutant-induced transformed cells
Keywords: Aurka; Aurora kinase; Epo; erythropoietin; EpoR; erythropoietin receptor; JAK2; Janus kinase 2; MPNs; myeloproliferative neoplasms; RT-PCR; reverse transcriptase-polymerase chain reaction; STAT5; signal transducers and activators of transcription 5; TAE;